SCHEMBL4729142

SCHEMBL4729142

O=C(Nc1ccccc1[N+](=O)[O-])C(F)F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ KCNMA1 Q12791 1/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ PDK1 Q15118 1/20 0.55
▸ PDK2 Q15119 1/20 0.55
▸ PDK3 Q15120 1/20 0.55
▸ PDK4 Q16654 1/20 0.55
▸ PHGDH O43175 1/20 0.54
▸ RAB9A P51151 3/20 0.52
▸ GAA P10253 2/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ MAPT P10636 2/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.50
▸ POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11332310 0.84 KMT2A (0.73) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL13390947 0.83 KMT2A (0.63) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL6857920 0.80 KMT2A (0.73) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL11758088 0.80 KMT2A (0.58) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL11758703 0.80 KMT2A (0.58) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL1509271 0.80 KMT2A (0.58) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL1745798 0.79 KMT2A (0.71) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL175272 0.79 MEN1 (0.71) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL113558 0.79 MEN1 (0.71) KMT2AMEN1KCNMA1NPC1PDK1
SCHEMBL6377318 0.79 KMT2A (0.71) KMT2AMEN1KCNMA1NPC1PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008032060-A1 4-BENZIMIDAZ0LYL-6-M0RPH0LIN0-2-PIPERAZINYLPYRIMIDINE DERIVATIVES AS P13K AND MTOR INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-03-20 — — WO disclosed
WO-2008032041-A1 PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST PI3K ENZYMES ASTRAZENECA AB (SE) 2008-03-20 — — WO disclosed
WO-2008032077-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2008-03-20 — — WO disclosed
Send feedback